Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP617805.RA_l1J9xPjEjpTaL_Ba4PSl2jN7fVP4RFOw6L_SU8CzJM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP617805.RA_l1J9xPjEjpTaL_Ba4PSl2jN7fVP4RFOw6L_SU8CzJM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP617805.RA_l1J9xPjEjpTaL_Ba4PSl2jN7fVP4RFOw6L_SU8CzJM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP617805.RA_l1J9xPjEjpTaL_Ba4PSl2jN7fVP4RFOw6L_SU8CzJM130_provenance.
- befree-2016 importedOn "2016-02-19" NP617805.RA_l1J9xPjEjpTaL_Ba4PSl2jN7fVP4RFOw6L_SU8CzJM130_provenance.
- NP617805.RA_l1J9xPjEjpTaL_Ba4PSl2jN7fVP4RFOw6L_SU8CzJM130_assertion wasGeneratedBy ECO_0000203 NP617805.RA_l1J9xPjEjpTaL_Ba4PSl2jN7fVP4RFOw6L_SU8CzJM130_provenance.
- NP617805.RA_l1J9xPjEjpTaL_Ba4PSl2jN7fVP4RFOw6L_SU8CzJM130_assertion wasDerivedFrom befree-2016 NP617805.RA_l1J9xPjEjpTaL_Ba4PSl2jN7fVP4RFOw6L_SU8CzJM130_provenance.
- NP617805.RA_l1J9xPjEjpTaL_Ba4PSl2jN7fVP4RFOw6L_SU8CzJM130_assertion SIO_000772 17602077 NP617805.RA_l1J9xPjEjpTaL_Ba4PSl2jN7fVP4RFOw6L_SU8CzJM130_provenance.
- NP617805.RA_l1J9xPjEjpTaL_Ba4PSl2jN7fVP4RFOw6L_SU8CzJM130_assertion evidence source_evidence_literature NP617805.RA_l1J9xPjEjpTaL_Ba4PSl2jN7fVP4RFOw6L_SU8CzJM130_provenance.
- NP617805.RA_l1J9xPjEjpTaL_Ba4PSl2jN7fVP4RFOw6L_SU8CzJM130_assertion description "[To evaluate the immunological and clinical response as well as the safety of the optimized peptide telomerase reverse transcriptase p572Y (TERT572Y) presented by HLA-A*0201 in patients with advanced non-small-cell lung cancer (NSCLC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP617805.RA_l1J9xPjEjpTaL_Ba4PSl2jN7fVP4RFOw6L_SU8CzJM130_provenance.